Mobile Menu

Molecular Analysis for Precision Oncology ONLINE

When: April 16, 2024 Time: 3:00 pm

Oncological care increasingly relies on molecular tumour characterization techniques to enhance patient outcomes. However, the clinical utility of some of these methods remains uncertain, potentially affecting their integration into healthcare systems. With all these new advancements, it can be a challenge to stay up to date on the clinical applications and future prospects of these precision oncology techniques.

Join us for our latest webinar series, Molecular Analysis for Precision Oncology ONLINE, where we’ll hear insights from nine leading experts in the cancer genomics field, covering cutting-edge tumour characterisation techniques and their clinical applications.

By registering for this webinar, you will:

  • Gain insights into the latest genomic techniques that are being used for the molecular characterisation of tumours.
  • Understand how liquid biopsies can be used in early cancer detection, patient stratification and clinical decision making.
  • See real-world examples of how these precision medicine techniques are being used clinically, both within the UK and internationally.

This three-part webinar series will be held on Tuesday 16th, 23rd & 30th April 2024, at 3pm BST / 4pm CET/ 10am EDT.

**Please note that by registering for one webinar in the series, you will automatically be registered to all subsequent webinars**

Webinar 1: Genomics in Cancer Diagnostics

Tuesday 16th April, 3pm BST/ 4pm CST/ 10am EDT

In this webinar, we will explore the role of genomics in cancer detection, diagnosis and tumour characterisation, and its impact on oncological care.

Our speakers will discuss germline and somatic gene testing, the potential of liquid biopsies in early cancer detection, and the transformative capability of these methods in personalised cancer treatments.

Talk 1: Challenges and Opportunities for Implementing Liquid Biopsies into Routine Clinical Diagnostics

  • Elif Dagdan, Director, Center for Medical Genetics Bochum Germany

Talk 2: Personalized Therapy Unleashed: The Critical Role of HRD Testing

  • Tina Moser, Postdoctoral Researcher, Medical University Graz

Webinar 2: Molecular Characterisation in Cancer Care

Tuesday 23rd April, 3pm BST/ 4pm CST/ 10am EDT

Precision oncology methods can now be used at every point of the typical patient pathway, from diagnosis to disease progression. Molecular tools are now being used to enable clinicians to monitor progression, predict relapse and metastasis, and change the course of clinical care in line with these findings.

In this webinar, we will discover how molecular cancer testing is shaping our understanding of cancer evolution, how this aids clinical decision making, and what future developments we can expect in the coming years.

Talk 1: Molecular Characterisation of Ovarian Cancers & Patient Stratification for Precision Oncology

  • Robb Hollis, Scientist, CRUK Scotland Centre, University of Edinburgh

Talk 2: GALEAS: Precision Diagnostics Guiding Clinical Decisions- From Solid Tumor to Liquid Biopsy

  •  Katie Shepherd, Clinical Specialist, Nonacus

Talk 3: Genomic Technologies That Are Shaping Clinical Cancer Care in the NHS

  • Gareth Gerrard, Clinical Scientist and Scientific Lead for Cancer Genomics (South East Genomic Laboratory Hub), Guy’s and St Thomas’ NHS Foundation Trust

Talk 4: Patient Stratification & Precision Medicine Supported by Liquid Biopsies

  • Simon Heeke, Liquid Biopsy Translational Working Group Leader, Department of Thoracic Head/ Neck Medical Oncology, MD Anderson Cancer Center

Webinar 3: Precision Oncology Now and in the Future

Tuesday 30th April, 3pm BST/ 4pm CST/ 10am EDT

This webinar closes of our series by highlighting current advances in studying and analysing tumor heterogeneity using single-cell sequencing. Using epigenomic, metabolomic and spatial data, our speakers will show how exposing multi-omic cellular heterogeneity creates pathways to new biomarkers, drug pathways and, ultimately, treatments.

Cancer has historically been the prime example of a disease that benefits from precision medicine approaches, and now we’re seeing progress in integrating these new technologies into the cancer treatment pathway.

This webinar will focus on how precision oncology technologies are translating from research to the clinic, and what challenges we must overcome before these techniques become routine. It will also showcase how the management of cancer is evolving for certain types of malignancies, and what you can expect to see becoming standard practice in healthcare services going forward.

Talk 1: Optimizing Urinary Proteomes as a Liquid Biopsy for Prostate Cancer

  • Thomas Kislinger, Professor, University of Toronto

Talk 2: Dynamic Precision Medicine: A New Approach to Therapy Resistance

  • Robert Beckman, Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center

Talk 3: Circulating Tumor Cells as a Non-Invasive Glioblastoma Approach to Study Recurrence Events and Develop a Challenging Diagnostic Tool

  • Francesca Lessi, Researcher, Fondazione Pisana per la Scienza

Register here:


Article Search